Verso (VRS) At $16.92 Forms Top; Perceptive Advisors Has Lifted Its Assembly Biosciences (ASMB) Stake

Perceptive Advisors Llc increased Assembly Biosciences Inc (ASMB) stake by 21.45% reported in 2017Q4 SEC filing. Perceptive Advisors Llc acquired 94,793 shares as Assembly Biosciences Inc (ASMB)’s stock rose 21.23%. The Perceptive Advisors Llc holds 536,626 shares with $24.28 million value, up from 441,833 last quarter. Assembly Biosciences Inc now has $917.89M valuation. The stock increased 0.22% or $0.1 during the last trading session, reaching $44.93. About 372,582 shares traded or 79.04% up from the average. Assembly Biosciences, Inc. (NASDAQ:ASMB) has risen 110.93% since April 17, 2017 and is uptrending. It has outperformed by 99.38% the S&P500.

Verso Corporation (VRS) formed multiple top with $17.43 target or 3.00% above today’s $16.92 share price. Verso Corporation (VRS) has $582.99 million valuation. The stock increased 0.36% or $0.06 during the last trading session, reaching $16.92. About 221,271 shares traded. Verso Corporation (NYSE:VRS) has risen 187.02% since April 17, 2017 and is uptrending. It has outperformed by 175.47% the S&P500.

Among 2 analysts covering Verso Corporation (NYSE:VRS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Verso Corporation has $25 highest and $11.25 lowest target. $22’s average target is 30.02% above currents $16.92 stock price. Verso Corporation had 8 analyst reports since July 27, 2016 according to SRatingsIntel. The stock of Verso Corporation (NYSE:VRS) earned “Buy” rating by FBR Capital on Wednesday, December 20. The stock of Verso Corporation (NYSE:VRS) has “Buy” rating given on Friday, March 9 by FBR Capital. The rating was initiated by BWS Financial on Wednesday, July 27 with “Buy”. BWS Financial upgraded the stock to “Strong Buy” rating in Wednesday, October 18 report. As per Friday, November 17, the company rating was maintained by BWS Financial. The stock of Verso Corporation (NYSE:VRS) earned “Buy” rating by FBR Capital on Friday, February 16.

Analysts await Verso Corporation (NYSE:VRS) to report earnings on May, 17. They expect $0.60 EPS, up 198.36% or $1.21 from last year’s $-0.61 per share. VRS’s profit will be $20.67 million for 7.05 P/E if the $0.60 EPS becomes a reality. After $1.04 actual EPS reported by Verso Corporation for the previous quarter, Wall Street now forecasts -42.31% negative EPS growth.

Perceptive Advisors Llc decreased Pfenex Inc (NYSEMKT:PFNX) stake by 326,200 shares to 519,773 valued at $1.38M in 2017Q4. It also reduced Versartis Inc (NASDAQ:VSAR) stake by 400,000 shares and now owns 1.49 million shares. Abeona Therapeutics Inc was reduced too.

Assembly Biosciences, Inc. (NASDAQ:ASMB) Ratings Chart